rs755782051
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The ENST00000229554.10(RSPH4A):c.1393C>T(p.Arg465Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000991 in 1,613,922 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Synonymous variant affecting the same amino acid position (i.e. R465R) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
ENST00000229554.10 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RSPH4A | NM_001010892.3 | c.1393C>T | p.Arg465Ter | stop_gained | 3/6 | ENST00000229554.10 | NP_001010892.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RSPH4A | ENST00000229554.10 | c.1393C>T | p.Arg465Ter | stop_gained | 3/6 | 1 | NM_001010892.3 | ENSP00000229554 | P1 | |
RSPH4A | ENST00000368581.8 | c.1393C>T | p.Arg465Ter | stop_gained | 3/5 | 1 | ENSP00000357570 | |||
RSPH4A | ENST00000368580.4 | c.922-1467C>T | intron_variant | 5 | ENSP00000357569 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152062Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000239 AC: 6AN: 251300Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135844
GnomAD4 exome AF: 0.00000889 AC: 13AN: 1461860Hom.: 0 Cov.: 32 AF XY: 0.00000688 AC XY: 5AN XY: 727232
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152062Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74252
ClinVar
Submissions by phenotype
Primary ciliary dyskinesia Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 07, 2017 | Loss-of-function variants in RSPH4A are known to be pathogenic (PMID: 19200523). For these reasons, this variant has been classified as Pathogenic. This variant has been reported in an individual affected with primary ciliary dyskinesia (PMID: 25789548). This variant is present in population databases (rs755782051, ExAC 0.02%). This sequence change creates a premature translational stop signal (p.Arg465*) in the RSPH4A gene. It is expected to result in an absent or disrupted protein product. - |
not provided Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | Department of Pathology and Laboratory Medicine, Sinai Health System | - | The RSPH4A p.R465* variant was identified in the literature as a homozygous variant in 1 of 16 families with Primary ciliary dyskinesia (PCD) (Frommer_2015_PMID:25789548). The variant was identified in dbSNP (ID: rs755782051) and ClinVar (classified as pathogenic by Invitae). The variant was identified in control databases in 6 of 251300 chromosomes at a frequency of 0.00002388 (Genome Aggregation Database March 6, 2019, v2.1.1). The variant was observed in the following populations: Latino in 5 of 34586 chromosomes (freq: 0.000145) and European (non-Finnish) in 1 of 113666 chromosomes (freq: 0.000009), but was not observed in the African, Ashkenazi Jewish, East Asian, European (Finnish), Other, or South Asian populations. The c.1393C>T variant leads to a premature stop codon at position 465 which is predicted to lead to a truncated or absent protein and loss of function. Loss of function variants of the RSPH4A gene are an established mechanism of disease in PCD and are the type of variant expected to cause the disorder when found in the homozygous or compound heterozygous state. The variant occurs outside of the splicing consensus sequence and two of four in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) predict a greater than 10% difference in splicing. In summary, based on the above information this variant meets our laboratory’s criteria to be classified as pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at